BMS-986278

DB18011InvestigationalSmall molecule

BMS-986278: Overview.

Chemical structure of BMS-986278
Formula / weight
C22H31N5O5 · 445.52 g/mol (avg)
Also known as
(1s,3s)-3-((2-methyl-6-(1-methyl-5-(((methyl(propyl)carbamoyl)oxy)methyl)-1h-1,2,3-triazol-4-yl)pyridin-3-yl)oxy)cyclohexane-1-carboxylic acid · Admilparant · Cyclohexanecarboxylic acid, 3-((2-methyl-6-(1-methyl-5-((((methylpropylamino)carbonyl)oxy)methyl)-1h-1,2,3-triazol-4-yl)-3-pyridinyl)oxy)-, (1s,3s)-
Code names
BMS-986278

Resolves to

Compound
UNII4UN9AOU6G8CAS2170126-74-4ChEMBLCHEMBL5087506
Structure
InChIKeyUEUNDURNLYLSNB-HOTGVXAUSA-NSMILESCCCN(C)C(=O)OCC1=C(N=NN1C)C1=CC=C(O[C@H]2CCC[C@@H](C2)C(O)=O)C(C)=N1
Targets
Q92633LPAR1

What you can answer from here — as of September 18, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with BMS-986278, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In